Vanderbilt earns accreditation with commendation from Commission on Cancer
Vanderbilt Medical Center and Vanderbilt-Ingram Cancer Center have been granted three-year accreditation with commendation by the Commission on Cancer (CC) of the American College of Surgeons (ACS).
The accreditation program sets quality-of-care standards for cancer programs and reviews the programs to ensure they conform to those standards. Accreditation is given only to those facilities that have voluntarily committed to providing the highest level of quality cancer care and that undergo a rigorous evaluation process and review of their performance. To maintain accreditation, facilities must undergo an on-site review every three years.
“We are honored to receive this importation recognition from the Commission on Cancer,” said Mark Kelley, M.D., chief of the Division of Surgical Oncology and Endocrine Surgery. “We are very proud of the high quality of care delivered by the exceptional clinicians, nurses and staff in the Cancer Center. This national accreditation recognizes this fact and our leadership in advancing cancer care through research.”
VICC underwent the quality survey in May and received the highest possible rating. Inspectors evaluated the Cancer Center’s programs, which include cancer prevention, early detection, disease staging, optimal treatment, rehabilitation, surveillance for recurrent disease, psychosocial support and end-of-life care. By achieving the highest rating, VICC will be evaluated for eligibility for the commission’s Outstanding Achievement Award, to be announced later this year.
VICC is one of only two National Cancer Institute (NCI)-designated Comprehensive Cancer Programs in Tennessee and was recognized in that category.